Literature DB >> 12594308

Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency.

Jana Kralovicova1, Lennart Hammarström, Alessandro Plebani, A David B Webster, Igor Vorechovsky.   

Abstract

Selective IgA deficiency (IgAD) and common variable immunodeficiency (CVID) are the most common primary immunodeficiencies in humans. A high degree of familial clustering, marked differences in the population prevalence among ethnic groups, association of IgAD and CVID in families, and a predominant inheritance pattern in multiple-case pedigrees have suggested a strong, shared genetic predisposition. Previous genetic linkage, case-control, and family-based association studies mapped an IgAD/CVID susceptibility locus, designated IGAD1, to the MHC, but its precise location within the MHC has been controversial. We have analyzed a sample of 101 multiple- and 110 single-case families using 36 markers at the IGAD1 candidate region and mapped homozygous stretches across the MHC shared by affected family members. Haplotype analysis, linkage disequilibrium, and homozygosity mapping indicated that HLA-DQ/DR is the major IGAD1 locus, strongly suggesting the autoimmune pathogenesis of IgAD/CVID. This is supported by the highest excess of allelic sharing at 6p in the genome-wide linkage analysis of 101 IgAD/CVID families using 383 marker loci, by previously reported restrictions of the T cell repertoires in CVID, the presence of autoantibodies, impaired T cell activation, and a dysregulation of a number of genes in the targeted immune system. IgAD/CVID may thus provide a useful model for the study of pathogenesis and novel therapeutic strategies in autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12594308     DOI: 10.4049/jimmunol.170.5.2765

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

Review 1.  Therapeutic strategies in common variable immunodeficiency.

Authors:  W A Carrock Sewell; Matthew Buckland; Stephen R A Jolles
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Molecular analysis of B-cell differentiation in selective or partial IgA deficiency.

Authors:  T Asano; H Kaneko; T Terada; Y Kasahara; T Fukao; K Kasahara; N Kondo
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

3.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

Review 4.  Human B cell defects in perspective.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

Review 5.  TACI mutation in common variable immunodeficiency and IgA deficiency.

Authors:  Rima Rachid; Emanuela Castigli; Raif S Geha; Francisco A Bonilla
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

6.  HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition.

Authors:  Heather A Prentice; Georgia D Tomaras; Daniel E Geraghty; Richard Apps; Youyi Fong; Philip K Ehrenberg; Morgane Rolland; Gustavo H Kijak; Shelly J Krebs; Wyatt Nelson; Allan DeCamp; Xiaoying Shen; Nicole L Yates; Susan Zolla-Pazner; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Jaranit Kaewkungwal; Punnee Pitisuttithum; Guido Ferrari; M Juliana McElrath; David C Montefiori; Robert T Bailer; Richard A Koup; Robert J O'Connell; Merlin L Robb; Nelson L Michael; Peter B Gilbert; Jerome H Kim; Rasmi Thomas
Journal:  Sci Transl Med       Date:  2015-07-15       Impact factor: 17.956

Review 7.  Perspectives on common variable immune deficiency.

Authors:  Joon H Park; Elena S Resnick; Charlotte Cunningham-Rundles
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

8.  [Adult-onset primary immunodeficiencies].

Authors:  S Gadola; U Salzer; H Schultz; B Grimbacher
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

Review 9.  The genetics of hypogammaglobulinemia.

Authors:  Bodo Grimbacher; Alejandro A Schäffer; Hans-Hartmut Peter
Journal:  Curr Allergy Asthma Rep       Date:  2004-09       Impact factor: 4.806

10.  Lymphoproliferative Disease in CVID: a Report of Types and Frequencies from a US Patient Registry.

Authors:  Elizabeth Yakaboski; Ramsay L Fuleihan; Kathleen E Sullivan; Charlotte Cunningham-Rundles; Elizabeth Feuille
Journal:  J Clin Immunol       Date:  2020-03-17       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.